LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Accuracy Evaluated for Schistosomiasis Tests

By LabMedica International staff writers
Posted on 03 May 2017
Image: A photomicrograph of an egg from the parasite Schistosoma mansoni reveals the egg’s characteristic lateral spine, from a stool specimen (Photo courtesy of the CDC).
Image: A photomicrograph of an egg from the parasite Schistosoma mansoni reveals the egg’s characteristic lateral spine, from a stool specimen (Photo courtesy of the CDC).
The unprecedented increase in number of African refugees arriving in Europe is confronting clinicians and general practitioners with the question of whether or not and how to screen migrants from endemic regions for Schistosoma mansoni infection.

Schistosoma mansoni is a significant parasite of humans, a trematode that is one of the major agents of the disease schistosomiasis, which is one type of helminthiasis, a neglected tropical disease. S. mansoni, the cause of intestinal schistosomiasis, is the most widespread of the human-infecting schistosomes, and is present in 54 countries. These countries are predominantly in South America and the Caribbean, Africa including Madagascar, and the Middle East.

Scientists at the Swiss Tropical and Public Health Institute and a Dutch colleague assessed the accuracy of three different diagnostic tests for S. mansoni infection: stool microscopy with the samples prepared by sedimentation technique; serology, and a point-of-care circulating cathodic antigen (POC-CCA) urine cassette test, in 107 newly arrived asymptomatic Eritrean refugees in Switzerland.

The team found that 63 (59%) study participants were tested positive by at least one of the three methods. Thirty-seven participants (35%) were considered to have active schistosomiasis, either due to the detection of parasite eggs in stool and/or the presence of a concordant positive serology and urine POC-CCA test, which the scientists considered to be a suitable surrogate marker of active infection. Of 23 microscopy-positive participants, 22 were positive in serology (95.7% sensitivity) and 21 were positive in the urine POC-CCA test (91.3% sensitivity). The combination of serology and urine POC-CCA testing detected all 23 microscopy-positive study participants (100% sensitivity).

The authors concluded that with a sensitivity of 100% (95% confidence interval (CI): 82.2-100%), the combination of serology plus urine POC-CCA testing appears to be the most sensitive screening option for asymptomatic S. mansoni infection in Eritrean refugees, when compared to stool sedimentation microscopy which requires the employment of a skilled microscopist. The study was published on April 19, 2017, in the journal Clinical Infectious Diseases.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Pipette
Accumax Smart Series

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more